PKU HealthCare Corp Ltd (SHE:000788) — Market Cap & Net Worth
Market Cap & Net Worth: PKU HealthCare Corp Ltd (000788)
PKU HealthCare Corp Ltd (SHE:000788) has a market capitalization of $533.74 Million (CN¥3.65 Billion) as of May 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #12207 globally and #3771 in its home market, demonstrating a -5.99% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PKU HealthCare Corp Ltd's stock price CN¥6.12 by its total outstanding shares 595987425 (595.99 Million). Analyse 000788 cash flow conversion to see how efficiently the company converts income to cash.
PKU HealthCare Corp Ltd Market Cap History: 2015 to 2026
PKU HealthCare Corp Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.29 Billion to $533.74 Million (-5.56% CAGR).
PKU HealthCare Corp Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PKU HealthCare Corp Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.25x
PKU HealthCare Corp Ltd's market cap is 0.25 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.79x
PKU HealthCare Corp Ltd's market cap is 3.79 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.29 Billion | $2.01 Billion | $25.03 Million | 0.64x | 51.43x |
| 2016 | $1.21 Billion | $2.07 Billion | $12.56 Million | 0.59x | 96.65x |
| 2017 | $744.02 Million | $2.15 Billion | $34.26 Million | 0.35x | 21.72x |
| 2018 | $446.81 Million | $2.32 Billion | $45.18 Million | 0.19x | 9.89x |
| 2019 | $571.74 Million | $2.51 Billion | $50.19 Million | 0.23x | 11.39x |
| 2020 | $527.11 Million | $1.98 Billion | $39.18 Million | 0.27x | 13.45x |
| 2021 | $588.06 Million | $2.24 Billion | $43.14 Million | 0.26x | 13.63x |
| 2022 | $640.56 Million | $2.08 Billion | $55.61 Million | 0.31x | 11.52x |
| 2023 | $577.72 Million | $2.19 Billion | $44.36 Million | 0.26x | 13.02x |
| 2024 | $523.27 Million | $2.06 Billion | $137.99 Million | 0.25x | 3.79x |
Competitor Companies of 000788 by Market Capitalization
Companies near PKU HealthCare Corp Ltd in the global market cap rankings as of May 4, 2026.
Key companies related to PKU HealthCare Corp Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.15 |
PKU HealthCare Corp Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, PKU HealthCare Corp Ltd's market cap moved from $1.29 Billion to $ 533.74 Million, with a yearly change of -5.56%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥533.74 Million | +0.16% |
| 2025 | CN¥532.86 Million | +1.83% |
| 2024 | CN¥523.27 Million | -9.42% |
| 2023 | CN¥577.72 Million | -9.81% |
| 2022 | CN¥640.56 Million | +8.93% |
| 2021 | CN¥588.06 Million | +11.56% |
| 2020 | CN¥527.11 Million | -7.81% |
| 2019 | CN¥571.74 Million | +27.96% |
| 2018 | CN¥446.81 Million | -39.95% |
| 2017 | CN¥744.02 Million | -38.71% |
| 2016 | CN¥1.21 Billion | -5.71% |
| 2015 | CN¥1.29 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of PKU HealthCare Corp Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $533.74 Million USD |
| MoneyControl | $533.74 Million USD |
| MarketWatch | $533.74 Million USD |
| marketcap.company | $533.74 Million USD |
| Reuters | $533.74 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PKU HealthCare Corp Ltd
PKU HealthCare Corp.,Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, pharmaceutical distribution, and medical services in China. The company offers products in various categories, including cardiovascular and cerebrovascular, antimicrobial, antipyretic and analgesic, digestive system, oncology, anti-allergic, blood sugar and immunity reg… Read more